HCPLive Network

Cell-Cycle Progression Panel Identifies Prostate Cancer Risk

THURSDAY, March 28 (HealthDay News) -- The cell-cycle progression (CCP) gene panel is useful to improve the risk stratification for men with even low-risk, clinically localized prostate cancer, according to research published online March 4 in the Journal of Clinical Oncology.

Matthew R. Cooperberg, MD, MPH, of the University of California in San Francisco, and colleagues sought to validate a previously described genetic risk score called CCP (that provides a value calculated from the average expression of 31 CCP genes) and its ability to improve risk stratification in men with localized prostate cancer and predict recurrence after prostatectomy.

The researchers found that for each increase of one unit in the CCP score, the hazard ratio increased by 1.7, after adjusting for the patient's Cancer of the Prostate Risk Assessment Post-Surgical (CAPRA-S) score. Combining the CCP with the CAPRA-S score yielded consistently predictive outcomes across a range of clinical risk, including low-risk patients.

"The performance of the CCP score in this validation study was excellent," the authors write. "The score provided independent prognostic information after radical prostatectomy and may prove useful in helping guide decisions with respect to adjuvant treatment and in stratifying men for future adjuvant therapy studies."

Several authors disclosed financial ties to genetics firms. Myriad Genetics helped support the study.

Abstract
Full Text (subscription or payment may be required)



Further Reading
The leading cause of cancer related deaths in both men and women is lung cancer. The 5-year survival rate of lung cancer is only 16%, as 75% of patients with lung cancer are presented with symptoms of advanced disease.
Simulations demonstrate that an excise tax on sugar-sweetened beverages would be the most effective policy for reducing child obesity, according to research published online Aug. 26 in the American Journal of Preventive Medicine.
Overconfident people are better at convincing others that they're more talented than they really are, and therefore are more likely to get promotions and reach high-level positions, according to British researchers. Their findings were published online Aug. 27 in PLOS ONE.
For actinic keratoses, photodynamic therapy is associated with improved response compared with cryotherapy, according to a meta-analysis published online Aug. 27 in JAMA Dermatology.
Progress has been made toward widespread adoption of electronic health records, although there are still barriers to adoption of advanced use of EHRs, according to a report published by the Robert Wood Johnson Foundation.
For patients with hypertension, finding the right course of treatment can be critically important especially when other health factors are taken into consideration.
One accountable care organization saved $8.5 million and received a check from Medicare for $4.2 million after 17 months. Suddenly, they had physicians clamoring to join.
More Reading